Przemysław Mencel FCMA CGMA

TWITI INVESTMENTS is the largest BioTech and MedTech private investment fund in CEE with over 17-year experience of angel investment as well as operations and management of various innovative startup companies. We invest in dedicated teams of scientists and managers with entrepreneurial spirit, and support early-stage businesses looking to grow worldwide. TWITI INVESTMENTS fuels the growth and implementation of breakthrough technologies with financing, counseling, and networking changing current therapeutic approach. http://www.twiti.investments/

Cellis is a European biotech company, with a focus in cell-based oncology therapy, which has developed a breakthrough platform technology called Macrophage Drug Conjugate for the treatment of solid tumors. https://cellis.eu/

Lipid Systems is a developer of a liposomal technology designed for efficient drug delivery. The company's technology has the ability to produce liposomal formulations of medicines, medical devices, food supplements and active substances efficient in closing in liposomal carriers and allowing effective transport in the body, enabling doctors to provide targeted delivery of drugs. https://liposhell.eu/ https://lipidsystems.pl/

Eveline Cosmetics is a Polish cosmetics company and at the same time the biggest manufacturer and exporter of cosmetics in Poland, present on the market since 1983. https://en.eveline.eu/

International e-Commerce Group of several entities within which operate: full service performance marketing agency, multilingual contact center, logistics provider, softwarehouse, employment agency and financial service provider

Global responsibility for financial practices, strategy development and implementation. Strategic business partner the CEO, operating board and management team. Global hedging strategy for commodities and currencies. Provide management and guidance for business process improvement in the area of Finance and Information Technology, ensuring that the organization's financial practices are in line with statutory regulations and legislation. Work closely with Logistics, Shipping Operations and Letter of Credit Departments, managing the risks, transfer pricing and reporting on financial performance.

Recruited for short-term engagement focused on providing strategic, financial and business expertise to facilitate restructuration of the stock exchange listed daughter company to build its value for its shareholders. Provided decisive leadership and direction for daily business operations including sales tracking, cash flow planning and management and inventory management. Supervised and motivated total of 255 direct and indirect reports. Selected achievements: improved efficiency of operation of the organization and its financial performance as a result of restructuring of key areas of the company * cooperation with the Management Team to meet the company growth and profit objectives, implement business plans and improve business operations *identify business opportunities, conduct feasibility studies for potential markets.

Employed to improve financial and business operations, implement long term financial and systems strategies, align reporting and internal controls in compliance with IAS, IFRS and introduce end-to-end accountability for this commercial manufacturing and distribution company with $25M in revenue. Held P&L responsibility and managed staff of 60 including finance, logistics, HR and information technology. Directed all financial controls, accounting and reporting, taxes, Treasury, IT and internal audit functions. Established and satisfied regulatory and contractual reporting. Submitted monthly, quarterly and yearly reporting documents, ad hoc reports and actual versus budget variances. Led critical projects to implement financial systems, procedures and controls.

FCMA designation

ACMA, CGMA designation